Xora Innovation
Xora Innovation is a subsidiary of the Singapore sovereign investment fund, Temasek. It was established as an early-stage deeptech investment platform that identifies startups connected with the Singapore science and technology ecosystem (although the startup can be based anywhere in the world). Xora plans to invest as a lead or co-lead in seed or Series A rounds, with later-stage investments being handled through Temasek. As of July 2021, Xora has invested in two companies based in Singapore: Allozymes, which provides enzyme engineering services, and Nuevocor, which is developing gene therapy for certain heart diseases.
RECOMMENDED
